Rydapt (Midostaurin) is a prescription medicine used to treat certain types of blood cell cancer (acute myeloid leukemia- AML) that is newly diagnosed FLT3 mutation positive as detected by an FDA-approved test. Midostaurin is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).

Rydapt manufactured by Novartis Pharma Ltd. in Germany.

Midostaurin have to take orally twice daily with food.

    Inquiry & Order

    Please prove you are human by selecting the Flag.

    Side Effects

    The most common side effects are:

    Febrile neutropenia (low level of white blood cells with fever), nausearednesspainvomitingheadachebruisingmuscle or bone pain, nose bleeds, hyperglycemia (high blood sugar levels), upper respiratory infection, QT prolongation (abnormal electrocardiogram), diarrheaconstipationfever.

    The above information comes from the Internet. Please consult with doctor for medical advice.

      Inquiry & Order

      Please prove you are human by selecting the Tree.

      PI & Suggestions

      Midostaurin_FDA_PI_04_17

      * Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice. All Names, logos, trademarks are property of their respective owners. Watermarks, QR code used for identification purposes only.

        Inquiry & Order

        Please prove you are human by selecting the Tree.

        There are no reviews yet.

        Be the first to review “Midostaurin (Rydapt 25mg)Rx”